Study Title
18-FDG Tumour Metabolism Changes in PDL1 Superior to 50% Stage III/IV Non Small Cell Lung Cancer During First Line Treatment With Pembrolizumab
Study Details
Description:
The aim of this study is to describe the early dynamics of 18-FDG uptake in non smal cell lung cancer during first line treatment with pembrolizumab, and to evaluate whether or not they differ according to treatment response at 3 months.
Sponsor:
Centre Henri Becquerel
Contacts:
Stephanie Becker, MDstephanie.becker@chb.unicancer.fr
+33232888247
Doriane Richard, PhDdoriane.richard@chb.unicancer.fr
+33232082985
Government Study Link:
NCT03832348 - Click here to see study onClinicalTrials.gov